Alignment Healthcare (ALHC) shares surged 25.1% to close at $19.20 on the latest trading session, reversing a previous 10.6% decline over the past month. This sharp rise followed the company’s presentation at the Goldman Sachs 47th Annual Global Healthcare Conference in Florida, where CEO John Kao emphasized the company’s medical management strengths and plans to enter larger markets by 2027.
Alignment Healthcare is projected to report quarterly earnings of $0.13 per share, reflecting an 85.7% year-over-year increase, along with anticipated revenues of $1.31 billion, a 29% rise from the previous year. The company has also recently been recognized on the Fortune 1000 list for 2026 for its strong financial performance.
As of now, Alignment Healthcare holds a Zacks Rank of #1 (Strong Buy), indicating positive investor sentiment. In comparison, Bausch + Lomb (BLCO) closed 3.1% higher at $15.65, with a forthcoming earnings estimate of $0.16 per share, marking an increase of 128.6% from last year.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
